The Performance of Peroral Endoscopic Myotomy in Sigmoid-Type Achalasia
DOI:
https://doi.org/10.33192/smj.v76i9.269112Keywords:
POEM, achalasia, sigmoid achalasiaAbstract
Objective: Sigmoid-type achalasia represents an advanced stage of achalasia characterized by significant dilation and tortuosity of the esophageal lumen. Considering the demonstrated efficacy of peroral endoscopic myotomy (POEM) in treating early-stage achalasia, this procedure may offer an alternative therapeutic approach for sigmoid-type achalasia. This study aimed to assess POEM’s feasibility and short-term efficacy in patients with sigmoid-type achalasia.
Materials and Methods: We enrolled 16 consecutive patients with sigmoid-type achalasia (eight with type 1 and eight with type 2). The anticipated outcomes were symptom relief during the 12-month follow-up period (evaluated through a reduction in Eckardt symptom scores), an acceptable incidence of procedure-related adverse events, and a decrease in esophageal diameter and barium height.
Results: POEM was successfully performed in all cases, with a median operative time of 118.50 minutes (range: 52–206 minutes). No serious complications associated with POEM were observed. During the 12-month follow-up period, the median Eckardt symptom score decreased from 6 (2-10) preoperatively to 1 (0-3) (P = 0.008). Complications were mucosal injuries (31.25% of cases), pneumoperitoneum (12.5%), and minor bleeding (6.25%), although no interventions were needed.
Conclusion: POEM procedure has exhibited favorable treatment outcomes, showcasing a high clinical success rate in addressing sigmoid-type achalasia. Despite the occurrence of acceptable adverse events, the procedure remains a viable alternative treatment or bridging therapy for sigmoid-type achalasia. Nonetheless, it is crucial to acknowledge that this procedure presents greater challenges in comparison to the treatment of typical achalasia.
References
O'Neill OM, Johnston BT, Coleman HG. Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2013;19(35):5806-12.
Fisichella PM, Patti MG. From Heller to POEM (1914-2014): a 100-year history of surgery for Achalasia. J Gastrointest Surg. 2014;18(10):1870-5.
Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver. 2015;9(4):449-63.
Spiess AE, Kahrilas PJ. Treating achalasia: from whalebone to laparoscope. JAMA [Internet]. 1998;280(7):638-42.
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy [Internet]. 2010;42(4):265-71.
Rerknimitr R, Akaraviputh T, Ratanachu-Ek T, Kongkam P, Pausawasdi N, Pisespongsa P. Current Status of GI Endoscopy in Thailand and Thai Association of Gastrointestinal Endoscopy (TAGE). Siriraj Med J. 1924;70(5):476-8.
Patti MG, Feo CV, Diener U, Tamburini A, Arcerito M, Safadi B, et al. Laparoscopic Heller myotomy relieves dysphagia in achalasia when the esophagus is dilated. Surg Endosc [Internet]. 1999;13(9):843-7.
Sweet MP, Nipomnick I, Gasper WJ, Bagatelos K, Ostroff JW, Fisichella PM, et al. The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation. J Gastrointest Surg [Internet]. 2008;12(1):159-65.
Eckardt VF. Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am. 2001;11(2):281-92, vi.
Nijhuis O, Zaninotto R, Roman G, Boeckxstaens S, Fockens GE, Langendam P. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol J. 2020;8(1):13-33.
Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil [Internet]. 2021;33(1):e14058.
Phalanusitthepha C, Inoue H, Ikeda H, Sato H, Sato C, Hokierti C. Peroral endoscopic myotomy for esophageal achalasia. Ann Transl Med [Internet]. 2014;2(3):31.
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc [Internet]. 2010;71(3):446-54.
Faccani E, Mattioli S, Lugaresi ML, Di Simone MP, Bartalena T, Pilotti V. Improving the surgery for sigmoid achalasia: long-term results of a technical detail. Eur J Cardiothorac Surg [Internet]. 2007;32(6):827-33.
Devaney EJ, Lannettoni MD, Orringer MB, Marshall B. Esophagectomy for achalasia: patient selection and clinical experience. Ann Thorac Surg [Internet]. 2001;72(3):854-8.
Panchanatheeswaran K, Parshad R, Rohila J, Saraya A, Makharia GK, Sharma R. Laparoscopic Heller’s cardiomyotomy: a viable treatment option for sigmoid oesophagus. Interact Cardiovasc Thorac Surg [Internet]. 2013;16(1):49-54.
Stavropoulos SN, Desilets DJ, Fuchs K-H, Gostout CJ, Haber G, Inoue H, et al. Per-oral endoscopic myotomy white paper summary. Surg Endosc [Internet]. 2014;28(7):2005-19.
Von Renteln D, Fuchs K-H, Fockens P, Bauerfeind P, Vassiliou MC, Werner YB, et al. Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology [Internet]. 2013;145(2):309-11.e1-3.
Xu J, Zhong C, Huang S, Zeng X, Tan S, Shi L, et al. Efficacy and safety of peroral endoscopic myotomy for sigmoid-type achalasia: A systematic review and meta-analysis. Front Med (Lausanne) [Internet]. 2021;8:677694.
Inoue H. Per-oral endoscopic myotomy: a series of 500 patients. Journal of the American College of Surgeons. 2015;2:256-64.
Miranda-García P, Casals-Seoane F, Gonzalez JM, Barthet M, Santander-Vaquero C. Per-oral endoscopic myotomy (POEM): a new endoscopic treatment for achalasia. Revista Española de Enfermedades Digestivas. 2017;109(10):719-26.
Li Q-L, Chen W-F, Zhou P-H, Yao L-Q, Xu M-D, Hu J-W, et al. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg [Internet]. 2013;217(3):442-51.
Myers JC, Cock C. Achalasia subtypes are front and center of the Chicago classification—strategies to overcome limitations in clinical application. Ann Esophagus [Internet]. 2020;3:24-24.
Published
How to Cite
License
Copyright (c) 2024 Siriraj Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.